#1 Clinical Trials Search in Europe

Bimatoprost

Bimatoprost is a medication that has been the subject of numerous clinical trials, primarily focusing on its effectiveness in treating glaucoma and ocular hypertension. These studies have explored various formulations and applications of bimatoprost, including eye drops, ocular inserts, and even its potential use for conditions like eyebrow hypotrichosis and androgenetic alopecia. This article summarizes key findings from recent clinical trials investigating bimatoprost’s safety, efficacy, and potential new uses.

Table of Contents

What is Bimatoprost?

Bimatoprost is a medication primarily used to treat certain eye conditions. It belongs to a class of drugs called prostaglandin analogs. Bimatoprost is known by various brand names, including Lumigan and Latisse, depending on its specific formulation and use[1][2].

Conditions Treated by Bimatoprost

Bimatoprost is primarily used to treat the following conditions:

  • Open-Angle Glaucoma: This is a type of glaucoma where the angle between the iris and cornea is open, but the eye’s drainage canals become clogged over time[3].
  • Ocular Hypertension: This condition is characterized by higher than normal pressure inside the eye, which can lead to glaucoma if left untreated[1].
  • Hypotrichosis of the Eyebrows: This is a condition where there is a lack of hair growth in the eyebrows. Bimatoprost (specifically Latisse) can be used to promote eyebrow hair growth[4].

How Bimatoprost Works

Bimatoprost works by reducing the pressure inside the eye (intraocular pressure or IOP). It does this by increasing the outflow of fluid (aqueous humor) from the eye. By lowering the pressure inside the eye, bimatoprost helps prevent damage to the optic nerve, which can lead to vision loss in conditions like glaucoma[3].

Forms and Administration of Bimatoprost

Bimatoprost comes in several forms:

  • Eye Drops: The most common form, typically administered once daily in the evening[1].
  • Ocular Insert: A newer form where a small insert is placed in the eye, slowly releasing the medication over time[2].
  • Topical Solution: Used for promoting eyebrow or eyelash growth[4].

Efficacy of Bimatoprost

Clinical trials have shown that bimatoprost is effective in lowering intraocular pressure in patients with open-angle glaucoma and ocular hypertension. For example, one study found that bimatoprost could lower IOP by an average of 6-8 mmHg over a 24-hour period[3]. Another study showed that bimatoprost was effective in increasing eyebrow prominence in patients with hypotrichosis of the eyebrows[4].

Potential Side Effects

Like all medications, bimatoprost can cause side effects. Common side effects include:

  • Eye redness: This is one of the most common side effects and is usually mild[1].
  • Eye irritation or discomfort: Some patients may experience a feeling of something in their eye or mild discomfort[2].
  • Changes in eye color: Long-term use can lead to darkening of the iris, especially in patients with light-colored eyes.
  • Eyelash changes: Bimatoprost can cause eyelashes to grow longer, thicker, and darker.

It’s important to discuss any side effects with your doctor, as they can help manage these issues or adjust your treatment if necessary.

Other Uses of Bimatoprost

In addition to its use in eye conditions, bimatoprost has been studied for other purposes:

  • Hair Growth: Bimatoprost has been investigated for its potential to treat male pattern baldness (androgenetic alopecia)[5].
  • Eyelash Growth: Bimatoprost (as Latisse) is FDA-approved for increasing eyelash length, thickness, and darkness in people with inadequate eyelashes.

These alternative uses are still being researched, and it’s important to only use bimatoprost as directed by a healthcare professional.

Aspect Details
Primary Uses Treatment of open-angle glaucoma and ocular hypertension
Mechanism of Action Lowers intraocular pressure (IOP)
Formulations Studied Eye drops (0.01%, 0.03%, 1%, 3%), ocular inserts
Alternative Applications Hypotrichosis of eyebrows, androgenetic alopecia
Common Side Effects Eye redness, discomfort, changes in eyelash growth
Study Durations Ranging from 6 weeks to 13 months
Comparison Treatments Latanoprost, placebo, standard of care
Special Formulations Preservative-free, sustained-release (SR)
Outcome Measures IOP reduction, safety profile, patient comfort, retention duration (for inserts)
Patient Populations Adults with glaucoma, ocular hypertension, hypotrichosis, androgenetic alopecia

FAQ

  • What is bimatoprost primarily used to treat? Bimatoprost is primarily used to treat open-angle glaucoma and ocular hypertension. It works by lowering intraocular pressure (IOP), which is the fluid pressure inside the eye.
  • How is bimatoprost typically administered? Bimatoprost is most commonly administered as eye drops. However, clinical trials have also explored other forms of administration, such as ocular inserts that can deliver the medication over an extended period.
  • Are there different concentrations of bimatoprost available? Yes, clinical trials have studied various concentrations of bimatoprost, including 0.01%, 0.03%, and even higher concentrations like 1% and 3% for specific applications.
  • Can bimatoprost be used for conditions other than glaucoma? While primarily used for glaucoma and ocular hypertension, some clinical trials have explored bimatoprost's potential for treating hypotrichosis of the eyebrows and androgenetic alopecia (male pattern baldness).
  • What are some common side effects of bimatoprost? Common side effects of bimatoprost can include eye redness (conjunctival hyperemia), eye discomfort, and changes in eyelash growth. Clinical trials have closely monitored these and other potential adverse events.

Ongoing Clinical Trials on Bimatoprost

  • Study on the Effects of Bimatoprost SR and Timolol in Patients with Open-angle Glaucoma or Ocular Hypertension

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study Comparing Bimatoprost Eye Drops with Lumigan for Patients with Chronic Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Italy

  • Study on Glaucoma Treatment: Comparing Brimonidine, Pilocarpine Nitrate, and Brinzolamide in Patients with Newly Diagnosed Open-Angle Glaucoma

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Sweden

  • Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    1 1 1
    Investigated drugs:
    Bulgaria Czechia Denmark Germany Ireland Italy +1

  • Study on Long-term Safety and Effectiveness of Bimatoprost SR for Patients with Open-angle Glaucoma or Ocular Hypertension

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Poland Spain

Glossary

  • Intraocular Pressure (IOP): The fluid pressure inside the eye. Elevated IOP is a major risk factor for glaucoma and is the primary target for glaucoma treatments.
  • Open-Angle Glaucoma: A type of glaucoma where the angle between the iris and cornea remains open, but the eye's drainage canals become clogged over time, leading to increased intraocular pressure.
  • Ocular Hypertension: A condition where the pressure inside the eye (intraocular pressure) is higher than normal, but without detectable changes in vision or damage to the eye structure.
  • Hypotrichosis: A condition characterized by a lack of hair growth or hair thinning, often referring to inadequate eyebrow hair in the context of bimatoprost studies.
  • Androgenetic Alopecia: Also known as male pattern baldness, this is a common form of hair loss in men, sometimes treated experimentally with bimatoprost in clinical trials.
  • Ocular Insert: A small device placed in the eye to deliver medication over an extended period, used in some bimatoprost trials as an alternative to eye drops.
  • Conjunctival Hyperemia: Redness of the eye caused by dilated blood vessels in the conjunctiva, often monitored as a side effect in bimatoprost trials.
  • Macroscopic Conjunctival Hyperemia: Visible redness of the eye that can be observed without magnification, often graded on a scale in clinical trials.
  • Diurnal IOP: Intraocular pressure measurements taken at different times throughout the day to assess pressure fluctuations.
  • Endothelial Cell Count: A measure of the density of cells lining the inner surface of the cornea, sometimes monitored in long-term bimatoprost studies.

References

  1. https://clinicaltrials.gov/study/NCT01830140
  2. https://clinicaltrials.gov/study/NCT02537015
  3. https://clinicaltrials.gov/study/NCT04285580
  4. https://clinicaltrials.gov/study/NCT01387906
  5. https://clinicaltrials.gov/study/NCT02676310